Skip to main content Accesibility Help
×
×
Home

Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications

  • J. Alexandra Rowe (a1), Antoine Claessens (a1), Ruth A. Corrigan (a1) and Mònica Arman (a1)
Abstract

Severe malaria has a high mortality rate (15–20%) despite treatment with effective antimalarial drugs. Adjunctive therapies for severe malaria that target the underlying disease process are therefore urgently required. Adhesion of erythrocytes infected with Plasmodium falciparum to human cells has a key role in the pathogenesis of life-threatening malaria and could be targeted with antiadhesion therapy. Parasite adhesion interactions include binding to endothelial cells (cytoadherence), rosetting with uninfected erythrocytes and platelet-mediated clumping of infected erythrocytes. Recent research has started to define the molecular mechanisms of parasite adhesion, and antiadhesion therapies are being explored. However, many fundamental questions regarding the role of parasite adhesion in severe malaria remain unanswered. There is strong evidence that rosetting contributes to severe malaria in sub-Saharan Africa; however, the identity of other parasite adhesion phenotypes that are implicated in disease pathogenesis remains unclear. In addition, the possibility of geographic variation in adhesion phenotypes causing severe malaria, linked to differences in malaria transmission levels and host immunity, has been neglected. Further research is needed to realise the untapped potential of antiadhesion adjunctive therapies, which could revolutionise the treatment of severe malaria and reduce the high mortality rate of the disease.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: J. Alexandra Rowe, Institute of Immunology and Infection Research, King's Buildings, University of Edinburgh, West Mains Rd, Edinburgh, EH9 3JT, UK. Tel: +44 131 6505492; Fax: +44-131-6506564; E-mail: Alex.Rowe@ed.ac.uk
References
Hide All
1Snow, R.W. et al. (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434, 214-217
2Marsh, K. et al. (1995) Indicators of life-threatening malaria in African children. New England Journal of Medicine 332, 1399-1404
3Dondorp, A.M. et al. (2008) The relationship between age and the manifestations of and mortality associated with severe malaria. Clinical Infectious Diseases 47, 151-157
4Miller, L.H. et al. (2002) The pathogenic basis of malaria. Nature 415, 673-679
5Dondorp, A.M. et al. (2008) Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. Journal of Infectious Diseases 197, 79-84
6Dondorp, A.M., Pongponratn, E. and White, N.J. (2004) Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Tropica 89, 309-317
7Planche, T. and Krishna, S. (2006) Severe malaria: metabolic complications. Current Molecular Medicine 6, 141-153
8Schofield, L. (2007) Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis. Immunology and Cell Biology 85, 130-137
9van der Heyde, H.C. et al. (2006) A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends in Parasitology 22, 503-508
10Mebius, R.E. and Kraal, G. (2005) Structure and function of the spleen. Nature Reviews Immunology 5, 606-616
11Udeinya, I.J. et al. (1981) Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells. Science 213, 555-557
12Udomsangpetch, R. et al. (1989) Plasmodium falciparum-infected erythrocytes form spontaneous erythrocyte rosettes. Journal of Experimental Medicine 169, 1835-1840
13Pain, A. et al. (2001) Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proceedings of the National Academy of Sciences of the United States of America 98, 1805-1810
14Bray, R.S. and Sinden, R.E. (1979) The sequestration of Plasmodium falciparum infected erythrocytes in the placenta. Transactions of the Royal Society of Tropical Medicine and Hygiene 73, 716-719
15Rogerson, S.J. et al. (2007) Malaria in pregnancy: pathogenesis and immunity. Lancet Infectious Diseases 7, 105-117
16Duffy, P.E. and Fried, M. (2005) Malaria in the pregnant woman. Current Topics in Microbiology and Immunology 295, 169-200
17Rowe, J.A. and Kyes, S.A. (2004) The role of Plasmodium falciparum var genes in malaria in pregnancy. Molecular Microbiology 53, 1011-1019
18White, N.J. (1987) Clinical and pathological aspects of severe malaria. Acta Leidensia 56, 27-47
19Erunkulu, O.A. et al. (1992) Severe malaria in Gambian children is not due to lack of previous exposure to malaria. Clinical and Experimental Immunology 89, 296-300
20Chotivanich, K. et al. (2000) Parasite multiplication potential and the severity of Falciparum malaria. Journal of Infectious Diseases 181, 1206-1209
21Simpson, J.A. et al. (1999) Red cell selectivity in malaria: a study of multiple-infected erythrocytes. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 165-168
22Deans, A.M. et al. (2006) Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence. American Journal of Tropical Medicine and Hygiene 74, 554-563
23Field, J.W. and Niven, J.C. (1937) A note on prognosis in relation to parasite counts in acute subtertian malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 30, 569-574
24Dondorp, A.M. et al. (2005) Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Medicine 2, e204
25Lyke, K.E. et al. (2003) Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. American Journal of Tropical Medicine and Hygiene 69, 253-259
26Carlson, J. et al. (1990) Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336, 1457-1460
27Treutiger, C.J. et al. (1992) Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. American Journal of Tropical Medicine and Hygiene 46, 503-510
28Ringwald, P. et al. (1993) Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines. Infection and Immunity 61, 5198-5204
29Rowe, A. et al. (1995) Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infection and Immunity 63, 2323-2326
30Newbold, C. et al. (1997) Receptor-specific adhesion and clinical disease in Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 57, 389-398
31Kun, J.F. et al. (1998) Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 110-114
32Heddini, A. et al. (2001) Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infection and Immunity 69, 5849-5856
33Rowe, J.A. et al. (2002) Nonimmune IgM, but not IgG binds to the surface of Plasmodium falciparum-infected erythrocytes and correlates with rosetting and severe malaria. American Journal of Tropical Medicine and Hygiene 66, 692-699
34Ho, M. et al. (1991) Rosette formation of Plasmodium falciparum-infected erythrocytes from patients with acute malaria. Infection and Immunity 59, 2135-2139
35Udomsangpetch, R. et al. (1996) Receptor specificity of clinical Plasmodium falciparum isolates: nonadherence to cell-bound E-selectin and vascular cell adhesion molecule-1. Blood 88, 2754-2760
36Angkasekwinai, P., Looareesuwan, S. and Chaiyaroj, S.C. (1998) Lack of significant association between rosette formation and parasitized erythrocyte adherence to purified CD36. Southeast Asian Journal of Tropical Medicine and Public Health 29, 41-45
37Chotivanich, K. et al. (2004) Platelet-induced autoagglutination of Plasmodium falciparum-infected red blood cells and disease severity in Thailand. Journal of Infectious Diseases 189, 1052-1055
38Baruch, D.I. et al. (1995) Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitised human erythrocytes. Cell 82, 77-87
39Smith, J.D. et al. (1995) Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82, 101-110
40Su, X.-Z. et al. (1995) A large and diverse family gene family (var) encodes 200-350 kD proteins implicated in the antigenic variation and cytoadherence of Plasmodium falciparum-infected erythocytes. Cell 82, 89-99
41Kyes, S.A. et al. (1999) Rifins: A second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America 96, 9333-9338
42Blythe, J.E. et al. (2008) Plasmodium falciparum STEVOR proteins are highly expressed in patient isolates and located in the surface membranes of infected red blood cells and the apical tips of merozoites. Infection and Immunity 76, 3329-3336
43Smith, J.D. et al. (2000) Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. Molecular and Biochemical Parasitology 110, 293-310
44Robinson, B.A., Welch, T.L. and Smith, J.D. (2003) Widespread functional specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bind CD36 analysed across a parasite genome. Molecular Microbiology 47, 1265-1278
45Kaestli, M. et al. (2006) Virulence of malaria is associated with differential expression of Plasmodium falciparum var gene subgroups in a case-control study. Journal of Infectious Diseases 193, 1567-1574
46Kyriacou, H.M. et al. (2006) Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Molecular and Biochemical Parasitology 150, 211-218
47Kyes, S.A., Kraemer, S.M. and Smith, J.D. (2007) Antigenic Variation in Plasmodium falciparum: Gene Organization and Regulation of the var Multigene Family. Eukaryotic Cell 6, 1511-1520
48Kraemer, S.M. and Smith, J.D. (2006) A family affair: var genes, PfEMP1 binding, and malaria disease. Current Opinion in Microbiology 9, 374-380
49Smith, J.D. et al. (2001) Decoding the language of var genes and Plasmodium falciparum sequestration. Trends in Parasitology 17, 538-545
50Roberts, D.J. et al. (1992) Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357, 689-692
51Marchiafava, E. and Bignami, A. (1894) On Summer-Autumnal Fever. The New Sydenham Society, London.
52Yipp, B.G. et al. (2000) Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow. Blood 96, 2292-2298
53McCormick, C.J. et al. (1997) Intercellular adhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells. Journal of Clinical Investigation 100, 2521-2529
54Yipp, B.G. et al. (2007) Differential roles of CD36, ICAM-1, and P-selectin in Plasmodium falciparum cytoadherence in vivo. Microcirculation 14, 593-602
55Ho, M. et al. (2000) Visualization of Plasmodium falciparum-endothelium interactions in human microvasculature: mimicry of leukocyte recruitment. Journal of Experimental Medicine 192, 1205-1211
56Udomsangpetch, R. et al. (1997) Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions. Journal of Immunology 158, 4358-4364
57Oquendo, P. et al. (1989) CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 58, 95-101
58Barnwell, J.W. et al. (1989) A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. Journal of Clinical Investigation 84, 765-772
59Greenwalt, D.E. et al. (1992) Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction and transfusion medicine. Blood 80, 1105-1115
60Daviet, L. et al. (1997) Characterization of two vaccinia CD36 recombinant-virus-generated monoclonal antibodies (10/5, 13/10): effects on malarial cytoadherence and platelet functions. European Journal of Biochemistry 243, 344-349
61Baruch, D.I. et al. (1999) CD36 peptides that block cytoadherence define the CD36 binding region for Plasmodium falciparum-infected erythrocytes. Blood 94, 2121-2127
62Baruch, D.I. et al. (1996) Plasmodium falciparum erythocyte membrane protein 1 is a parasitised erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. Proceedings of the National Academy of Sciences of the United States of America 93, 3497-3502
63Miller, L.H. et al. (2002) Definition of the minimal domain of CIDR1alpha of Plasmodium falciparum PfEMP1 for binding CD36. Molecular and Biochemical Parasitology 120, 321-323
64Smith, J.D. et al. (1998) Analysis of adhesive domains from the A4VAR Plasmodium falciparum erythrocyte membrane protein-1 identifies a CD36 binding domain. Molecular and Biochemical Parasitology 97, 133-148
65Baruch, D.I. et al. (1997) Identification of a region of PfEMP1 that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: conserved function with variant sequence. Blood 90, 3766-3775
66Klein, M.M. et al. (2008) The cysteine-rich interdomain region from the highly variable Plasmodium falciparum erythrocyte membrane protein-1 exhibits a conserved structure. PLoS Pathogens 4, e1000147
67Serghides, L. et al. (2003) CD36 and malaria: friends or foes? Trends in Parasitology 19, 461-469
68Marsh, K. et al. (1988) Plasmodium falciparum: the behavior of clinical isolates in an in vitro model of infected red blood cell sequestration. Experimental Parasitology 65, 202-208
69Rogerson, S.J. et al. (1999) Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria. American Journal of Tropical Medicine and Hygiene 61, 467-472
70Heddini, A. et al. (2001) Binding of Plasmodium falciparum-infected erythrocytes to soluble platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): frequent recognition by clinical isolates. American Journal of Tropical Medicine and Hygiene 65, 47-51
71Ho, M. et al. (1991) Clinical correlates of in vitro Plasmodium falciparum cytoadherence. Infection and Immunity 59, 873-878
72Ockenhouse, C.F. et al. (1991) Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. Journal of Infection Dis 164, 163-169
73Omi, K. et al. (2003) CD36 polymorphism is associated with protection from cerebral malaria. American Journal of Human Genetics 72, 364-374
74Berendt, A.R. et al. (1989) Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 341, 57-59
75Chakravorty, S.J. and Craig, A. (2005) The role of ICAM-1 in Plasmodium falciparum cytoadherence. European Journal of Cell Biology 84, 15-27
76Berendt, A.R. et al. (1992) The binding site on ICAM-1 for Plasmodium falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site. Cell 68, 71-81
77Ockenhouse, C.F. et al. (1992) Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirus. Cell 68, 63-69
78Tse, M.T. et al. (2004) Divergent binding sites on intercellular adhesion molecule-1 (ICAM-1) for variant Plasmodium falciparum isolates. Molecular Microbiology 51, 1039-1049
79Smith, J.D. et al. (2000) Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria. Proceedings of the National Academy of Sciences of the United States of America 97, 1766-1771
80Chattopadhyay, R. et al. (2004) Molecular analysis of the cytoadherence phenotype of a Plasmodium falciparum field isolate that binds intercellular adhesion molecule-1. Molecular and Biochemical Parasitology 133, 255-265
81Springer, A.L. et al. (2004) Functional interdependence of the DBLbeta domain and c2 region for binding of the Plasmodium falciparum variant antigen to ICAM-1. Molecular and Biochemical Parasitology 137, 55-64
82Howell, D.P. et al. (2008) Mapping a common interaction site used by Plasmodium falciparum Duffy binding-like domains to bind diverse host receptors. Molecular Microbiology 67, 78-87
83Craig, A. et al. (2000) A functional analysis of a natural variant of intercellular adhesion molecule-1 (ICAM-1Kilifi). Human Molecular Genetics 9, 525-530
84Fernandez-Reyes, D. et al. (1997) A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Human Molecular Genetics 6, 1357-1360
85Jenkins, N.E. et al. (2005) A polymorphism of intercellular adhesion molecule-1 is associated with a reduced incidence of nonmalarial febrile illness in Kenyan children. Clinical Infectious Diseases 41, 1817-1819
86Turner, G.D.H. et al. (1994) An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. American Journal of Pathology 145, 1057-1069
87Kwiatkowski, D. et al. (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336, 1201-1204
88Ho, M. et al. (1998) Characterization of Plasmodium falciparum-infected erythrocyte and P-selectin interaction under flow conditions. Blood 91, 4803-4809
89Senczuk, A.M. et al. (2001) Plasmodium falciparum erythrocyte membrane protein 1 functions as a ligand for P-selectin. Blood 98, 3132-3135
90Roberts, D.D. et al. (1985) Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature 318, 64-66
91Rock, E.P. et al. (1988) Thrombospondin mediates the cytoadherence of Plasmodium falciparum-infected red cells to vascular endothelium in shear flow conditions. Blood 71, 71-75
92Eda, S., Lawler, J. and Sherman, I.W. (1999) Plasmodium falciparum-infected erythrocyte adhesion to the type 3 repeat domain of thrombospondin-1 is mediated by a modified band 3 protein. Molecular and Biochemical Parasitology 100, 195-205
93Eda, S. and Sherman, I.W. (2002) Cytoadherence of malaria-infected red blood cells involves exposure of phosphatidylserine. Cellular Physiology and Biochemistry 12, 373-384
94Treutiger, C.J. et al. (1997) PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Nature Medicine 3, 1405-1408
95Chen, Q. et al. (2000) The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. Journal of Experimental Medicine 192, 1-10
96Casals-Pascual, C. et al. (2001) Short report: codon 125 polymorphism of CD31 and susceptibility to malaria. American Journal of Tropical Medicine and Hygiene 65, 736-737
97Kikuchi, M. et al. (2001) Association of adhesion molecule PECAM-1/CD31 polymorphism with susceptibility to cerebral malaria in Thais. Parasitology International 50, 235-239
98Ockenhouse, C.F. et al. (1992) Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. Journal of Experimental Medicine 176, 1183-1189
99Vogt, A.M. et al. (2003) Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1. Blood 101, 2405-2411
100Barragan, A. et al. (2000) The duffy-binding-like domain 1 of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a heparan sulfate ligand that requires 12 mers for binding. Blood 95, 3594-3599
101Skidmore, M.A. et al. (2008) Disruption of rosetting in Plasmodium falciparum malaria with chemically modified heparin and low molecular weight derivatives possessing reduced anticoagulant and other serine protease inhibition activities. Journal of Medicinal Chemistry 51, 1453-1458
102Chen, Q. et al. (1998) Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. Journal of Experimental Medicine 187, 15-23
103Hatabu, T. et al. (2003) Binding of Plasmodium falciparum-infected erythrocytes to the membrane-bound form of Fractalkine/CX3CL1. Proceedings of the National Academy of Sciences of the United States of America 100, 15942-15946
104Siano, J.P. et al. (1998) Short report: Plasmodium falciparum: cytoadherence to alpha(v)beta3 on human microvascular endothelial cells. American Journal of Tropical Medicine and Hygiene 59, 77-79
105Eda, S. and Sherman, I.W. (2004) Plasmodium falciparum-infected erythrocytes bind to the RGD motif of fibronectin via the band 3-related adhesin. Experimental Parasitology 107, 157-162
106Pouvelle, B. et al. (2007) Neural cell adhesion molecule, a new cytoadhesion receptor for Plasmodium falciparum-infected erythrocytes capable of aggregation. Infection and Immunity 75, 3516-3522
107Biswas, A.K. et al. (2007) Plasmodium falciparum uses gC1qR/HABP1/p32 as a receptor to bind to vascular endothelium and for platelet-mediated clumping. PLoS Pathogens 3, 1271-1280
108Pino, P. et al. (2003) Plasmodium falciparum-infected erythrocyte adhesion induces caspase activation and apoptosis in human endothelial cells. Journal of Infectious Diseases 187, 1283-1290
109Wilson, N.O. et al. (2008) Soluble factors from Plasmodium falciparum-infected erythrocytes induce apoptosis in human brain vascular endothelial and neuroglia cells. Molecular and Biochemical Parasitology 162, 172-176
110Yeo, T.W. et al. (2007) Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. Journal of Experimental Medicine 204, 2693-2704
111Weinberg, J.B. et al. (2008) Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. Current Opinion in Infectious Diseases 21, 468-475
112Serirom, S. et al. (2003) Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. American Journal of Pathology 162, 1651-1660
113Francischetti, I.M. et al. (2007) Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes. Journal of Thrombosis and Haemostasis 5, 155-165
114David, P.H. et al. (1988) Rosetting: a new cytoadherence property of malaria-infected erythrocytes. American Journal of Tropical Medicine and Hygiene 38, 289-297
115Kaul, D.K. et al. (1991) Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood 78, 812-819
116Rowe, J.A. et al. (1997) P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388, 292-295
117Rowe, J.A. et al. (2000) Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates. Journal of Immunology 165, 6341-6346
118Carlson, J. and Wahlgren, M. (1992) Plasmodium falciparum erythrocyte rosetting is mediated by promiscuous lectin-like interactions. Journal of Experimental Medicine 176, 1311-1317
119Handunnetti, S.M. et al. (1992) Involvement of CD36 on erythrocytes as a rosetting receptor for Plasmodium falciparum-infected erythrocytes. Blood 80, 2097-2104
120Russell, C. et al. (2005) Further definition of PfEMP-1 DBL-1alpha domains mediating rosetting adhesion of Plasmodium falciparum. Molecular and Biochemical Parasitology 144, 109-113
121Vigan-Womas, I. et al. (2008) An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype. Infection and Immunity 76, 5565-5580
122Scholander, C. et al. (1996) Novel fibrillar structure confers adhesive property to malaria-infected erythrocytes. Nature Medicine 2, 204-208
123Treutiger, C.J. et al. (1999) Rouleaux-forming serum proteins are involved in the rosetting of Plasmodium falciparum-infected erythrocytes. Experimental Parasitology 93, 215-224
124Ghumra, A. et al. (2008) Identification of residues in the Cmu4 domain of polymeric IgM essential for interaction with Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). Journal of Immunology 181, 1988-2000
125Helmby, H. et al. (1993) Rosetting Plasmodium falciparum-infected erythrocytes express unique strain-specific antigens on their surface. Infection and Immunity 61, 284-288
126Khera, R. and Das, N. (2009) Complement Receptor 1: Disease associations and therapeutic implications. Molecular Immunology 46, 761-772
127Cockburn, I.A. et al. (2004) A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proceedings of the National Academy of Sciences of the United States of America 101, 272-277
128Nagayasu, E. et al. (2001) CR1 density polymorphism on erythrocytes of falciparum malaria patients in Thailand. American Journal of Tropical Medicine and Hygiene 64, 1-5
129Teeranaipong, P. et al. (2008) A functional single-nucleotide polymorphism in the CR1 promoter region contributes to protection against cerebral malaria. Journal of Infectious Diseases 198, 1880-1891
130Udomsangpetch, R. et al. (1993) The effects of hemoglobin genotype and ABO blood group on the formation of rosettes by Plasmodium falciparum-infected red blood cells. American Journal of Tropical Medicine and Hygiene 48, 149-153
131Barragan, A. et al. (2000) Blood group A antigen is a coreceptor in Plasmodium falciparum rosetting. Infection and Immunity 68, 2971-2975
132Carlson, J. et al. (1994) Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation. Blood 84, 3909-3914
133Rowe, J.A. et al. (2007) Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proceedings of the National Academy of Sciences of the United States of America 104, 17471-17476
134Fry, A.E. et al. (2008) Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Human Molecular Genetics 17, 567-576
135Pathirana, S.L. et al. (2005) ABO-blood-group types and protection against severe, Plasmodium falciparum malaria. Annals of Tropical Medicine and Parasitology 99, 119-124
136Vogt, A.M. et al. (2004) Heparan sulphate identified on human erythrocytes: a Plasmodium falciparum receptor. Biochemical Journal 381, 593-597
137Wassmer, S.C. et al. (2004) Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion to activated endothelial cells. Journal of Infectious Diseases 189, 180-189
138Srivastava, K. et al. (2008) Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host and Microbe 4, 179-187
139Grau, G.E. et al. (2003) Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. Journal of Infectious Diseases 187, 461-466
140McMorran, B.J. et al. (2009) Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science 323, 797-800
141Wassmer, S.C. et al. (2008) Platelet-induced clumping of Plasmodium falciparum-infected erythrocytes from Malawian patients with cerebral malaria-possible modulation in vivo by thrombocytopenia. Journal of Infectious Diseases 197, 72-78
142Arman, M. et al. (2007) Platelet-mediated clumping of Plasmodium falciparum infected erythrocytes is associated with high parasitemia but not severe clinical manifestations of malaria in African children. American Journal of Tropical Medicine and Hygiene 77, 943-946
143Arman, M. and Rowe, J.A. (2008) Experimental conditions affect the outcome of Plasmodium falciparum platelet-mediated clumping assays. Malaria Journal 7, 243
144McGilvray, I.D. et al. (2000) Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. Blood 96, 3231-3240
145Urban, B.C. et al. (1999) Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400, 73-77
146Urban, B.C., Willcox, N. and Roberts, D.J. (2001) A role for CD36 in the regulation of dendritic cell function. Proceedings of the National Academy of Sciences of the United States of America 98, 8750-8755
147Elliott, S.R. et al. (2007) Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1. Infection and Immunity 75, 3621-3632
148Donati, D. et al. (2004) Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infection and Immunity 72, 5412-5418
149Artavanis-Tsakonas, K. et al. (2003) Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes. Journal of Immunology 171, 5396-5405
150Baratin, M. et al. (2007) Dissection of the role of PfEMP1 and ICAM-1 in the sensing of Plasmodium falciparum-infected erythrocytes by natural killer cells. PLoS ONE 2, e228
151D'Ombrain, M.C. et al. (2007) Plasmodium falciparum erythrocyte membrane protein-1 specifically suppresses early production of host interferon-gamma. Cell Host and Microbe 2, 130-138
152MacPherson, G.G. et al. (1985) Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. American Journal of Pathology 119, 385-401
153Taylor, T.E. et al. (2004) Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nature Medicine 10, 143-145
154Dondorp, A.M. (2008) Clinical significance of sequestration in adults with severe malaria. Transfusion Clinique et Biologique 15, 56-57
155Artavanis-Tsakonas, K., Tongren, J.E. and Riley, E.M. (2003) The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clinical and Experimental Immunology 133, 145-152
156Francischetti, I.M. (2008) Does activation of the blood coagulation cascade have a role in malaria pathogenesis? Trends in Parasitology 24, 258-263
157Seydel, K.B. et al. (2006) The distribution and intensity of parasite sequestration in comatose Malawian children. Journal of Infectious Diseases 194, 208–205
158WHO (2000) Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Transactions of the Royal Society of Tropical Medicine and Hygiene 94 Suppl 1, S1-90
159Bruneel, F. et al. (2003) The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. American Journal of Respiratory and Critical Care Medicine 167, 684-689
160Dondorp, A. et al. (2005) Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366, 717-725
161Skinner, T.S. et al. (1996) In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. International Journal for Parasitology 26, 519-525
162Wang, C.C. (1997) Validating targets for antiparasite chemotherapy. Parasitology 114 Suppl, S31-44
163Duffy, P.E., Craig, A.G. and Baruch, D.I. (2001) Variant proteins on the surface of malaria-infected erythrocytes–developing vaccines. Trends in Parasitology 17, 354-356
164Baruch, D.I. et al. (2002) Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line. Proceedings of the National Academy of Sciences of the United States of America 99, 3860-3865
165Chen, Q. et al. (2004) Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes. Vaccine 22, 2701-2712
166Gamain, B., Miller, L.H. and Baruch, D.I. (2001) The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes. Proceedings of the National Academy of Sciences of the United States of America 98, 2664-2669
167Baruch, D.I., Gamain, B. and Miller, L.H. (2003) DNA immunization with the cysteine-rich interdomain region 1 of the Plasmodium falciparum variant antigen elicits limited cross-reactive antibody responses. Infection and Immunity 71, 4536-4543
168Gandon, S. et al. (2003) Imperfect vaccination: some epidemiological and evolutionary consequences. Proceedings of the Royal Society B Biological Sciences 270, 1129-1136
169Yipp, B.G. et al. (2003) Src-family kinase signaling modulates the adhesion of Plasmodium falciparum on human microvascular endothelium under flow. Blood 101, 2850-2857
170Ho, M. et al. (2005) Ectophosphorylation of CD36 regulates cytoadherence of Plasmodium falciparum to microvascular endothelium under flow conditions. Infection and Immunity 73, 8179-8187
171Dondorp, A.M. et al. (2007) Levamisole inhibits sequestration of infected red blood cells in patients with falciparum malaria. Journal of Infectious Diseases 196, 460-466
172Gruarin, P. et al. (2001) Cytoadherence of Plasmodium falciparum-infected erythrocytes is mediated by a redox-dependent conformational fraction of CD36. Journal of Immunology 167, 6510-6517
173Dondorp, A.M. et al. (1997) Prognostic significance of reduced red blood cell deformability in severe falciparum malaria. American Journal of Tropical Medicine and Hygiene 57, 507-511
174Nuchsongsin, F. et al. (2007) Effects of malaria heme products on red blood cell deformability. American Journal of Tropical Medicine and Hygiene 77, 617-622
175Watt, G., Jongsakul, K. and Ruangvirayuth, R. (2002) A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria. Quarterly Journal of Medicine 95, 285-290
176Treeprasertsuk, S. et al. (2003) N-acetylcysteine in severe falciparum malaria in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 34, 37-42
177Arreesrisom, P. et al. (2007) Suppressive effects of the anti-oxidant N-acetylcysteine on the anti-malarial activity of artesunate. Parasitology International 56, 221-226
178Cooke, B.M. et al. (1998) A recombinant peptide based on PfEMP-1 blocks and reverses adhesion of malaria-infected red blood cells to CD36 under flow. Molecular Microbiology 30, 83-90
179Yipp, B.G. et al. (2003) Recombinant PfEMP1 peptide inhibits and reverses cytoadherence of clinical Plasmodium falciparum isolates in vivo. Blood 101, 331-337
180Dormeyer, M. et al. (2006) Rational design of anticytoadherence inhibitors for Plasmodium falciparum based on the crystal structure of human intercellular adhesion molecule 1. Antimicrobial Agents and Chemotherapy 50, 724-730
181Benelli, R. et al. (2002) Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biological Chemistry 383, 101-105
182Fassina, G. et al. (2004) Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clinical Cancer Research 10, 4865-4873
183Yoda, Y. et al. (2004) Different susceptibilities of Staphylococcus and Gram-negative rods to epigallocatechin gallate. Journal of Infection and Chemotherapy 10, 55-58
184Anstey, N.M. et al. (1996) Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. Journal of Experimental Medicine 184, 557-567
185Lopansri, B.K. et al. (2003) Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet 361, 676-678
186Yeo, T.W. et al. (2008) Pharmacokinetics of L-arginine in adults with moderately severe malaria. Antimicrobial Agents and Chemotherapy 52, 4381-4387
187Yeo, T.W. et al. (2008) Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations. Journal of Infectious Diseases 198, 602-608
188Yeo, T.W. et al. (2008) Safety profile of L-arginine infusion in moderately severe falciparum malaria. PLoS ONE 3, e2347
189Taoufiq, Z. et al. (2008) Rho kinase inhibition in severe malaria: thwarting parasite-induced collateral damage to endothelia. Journal of Infectious Diseases 197, 1062-1073
190Carlson, J. et al. (1992) Disruption of Plasmodium falciparum erythrocyte rosettes by standard heparin and heparin devoid of anticoagulant activity. American Journal of Tropical Medicine and Hygiene 46, 595-602
191Rowe, A. et al. (1994) Plasmodium falciparum: a family of sulphated glycoconjugates disrupts erythrocyte rosettes. Experimental Parasitology 79, 506-516
192Rogerson, S.J. et al. (1994) Sulfated glycoconjugates as disrupters of Plasmodium falciparum erythrocyte rosettes. American Journal of Tropical Medicine and Hygiene 51, 198-203
193Vogt, A.M. et al. (2006) Release of sequestered malaria parasites upon injection of a glycosaminoglycan. PLoS Pathogens 2, e100
194Kyriacou, H.M. et al. (2007) In vitro inhibition of Plasmodium falciparum rosette formation by Curdlan sulfate. Antimicrobial Agents and Chemotherapy 51, 1321-1326
195Kaneko, Y. et al. (1990) Inhibition of HIV-1 infectivity with curdlan sulfate in vitro. Biochemical Pharmacology 39, 793-797
196Havlik, I. et al. (2005) Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 99, 333-340
197Weisman, H.F. et al. (1990) Soluble human complement receptor type I: In vivo inhibitor of complement suppressing post-ischaemic myocardial inflammation and necrosis. Science 249, 146-151
198Keshavjee, S. et al. (2005) A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. Journal of Thoracic and Cardiovascular Surgery 129, 423-428
199Yazdanbakhsh, K. (2005) Review: complement receptor 1 therapeutics for prevention of immune hemolysis. Immunohematology 21, 109-118
200Ahrens, I., Bode, C. and Peter, K. (2005) Inhibition of platelet activation and aggregation. Handbook of Experimental Pharmacology 443-462
201Bennett, J.S. (2001) Novel platelet inhibitors. Annual Review of Medicine 52, 161-184
202Nacher, M. et al. (2001) Case-control studies on host factors in severe malaria. Trends in Parasitology 17, 253-254
203Montgomery, J. et al. (2006) Genetic Analysis of Circulating and Sequestered Populations of Plasmodium falciparum in Fatal Pediatric Malaria. Journal of Infectious Diseases 194, 115-122
204Krishna, S. et al. (1994) Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 67-73
205Rowe, J.A. et al. (2002) Positive correlation between rosetting and parasitemia in Plasmodium falciparum clinical isolates. American Journal of Tropical Medicine and Hygiene 66, 458-460
206Le Scanf, C. et al. (2008) Rosetting is associated with increased Plasmodium falciparum in vivo multiplication rate in the Saimiri sciureus monkey. Microbes and Infection 10, 447-451
207Clough, B., Atilola, F.A. and Pasvol, G. (1998) The role of rosetting in the multiplication of Plasmodium falciparum: rosette formation neither enhances nor targets parasite invasion into uninfected red cells. British Journal of Haematology 100, 99-104
208Deans, A.M. and Rowe, J.A. (2006) Plasmodium falciparum: Rosettes do not protect merozoites from invasion-inhibitory antibodies. Experimental Parasitology 112, 269-273
209David, P.H. et al. (1983) Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proceedings of the National Acadamy of Science of the United States of America 80, 5075-5079
210Willimann, K. et al. (1995) In vivo sequestration of Plasmodium falciparum-infected human erythrocytes: a severe combined immunodeficiency mouse model for cerebral malaria. Journal of Experimental Medicine 182, 643-653
211Pettersson, F. et al. (2005) Whole-body imaging of sequestration of Plasmodium falciparum in the rat. Infection and Immunity 73, 7736-7746
212McIntosh, R.S. et al. (2007) The importance of human FcgammaRI in mediating protection to malaria. PLoS Pathogens 3, e72
213Simmons, D.L. (2005) Anti-adhesion therapies. Current Opinion in Pharmacology 5, 398-404
214Aitman, T.J. et al. (2000) Malaria susceptibility and CD36 mutation. Nature 405, 1015-1016
215Ayodo, G. et al. (2007) Combining evidence of natural selection with association analysis increases power to detect malaria-resistance variants. American Journal of Human Genetics 81, 234-242
216Amodu, O.K. et al. (2005) Plasmodium falciparum malaria in south-west Nigerian children: is the polymorphism of ICAM-1 and E-selectin genes contributing to the clinical severity of malaria? Acta Tropica 95, 248-255
217Pain, A. et al. (2001) A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet 357, 1502-1503
218Bellamy, R., Kwiatkowski, D. and Hill, A.V. (1998) Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 312-316
219Ndiaye, R. et al. (2005) Genetic study of ICAM1 in clinical malaria in Senegal. Tissue Antigens 65, 474-480
220Fry, A.E. et al. (2008) Variation in the ICAM1 gene is not associated with severe malaria phenotypes. Genes and Immunity 9, 462-469
221Kun, J.F. et al. (1999) Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambarene, Gabon. American Journal of Tropical Medicine and Hygiene 61, 776-779
222Moulds, J.M. et al. (2001) Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 97, 2879-2885
223Thathy, V. et al. (2005) Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya. Malaria Journal 4, 54
224Zimmerman, P.A. et al. (2003) CR1 Knops blood group alleles are not associated with severe malaria in the Gambia. Genes and Immunity 4, 368-373
D.A., Warrell and H.M., Gilles eds (2002) Essential Malariology, 4th Edition, Oxford University Press.
I.W., Sherman ed. (2005) Molecular Approaches to Malaria, ASM Press.

For up-to-date information on malaria risks, epidemiology and prevention see:

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed